Glaucoma is a leading cause of irreversible blindness worldwide. As new treatments emerge, transparent reporting of adverse events (AEs) in clinical trials is essential to ensure patient safety. However, discrepancies persist in the reporting of serious adverse events (SAEs), other adverse events (OAEs), mortality, and participant withdrawals between clinical trial registries and their corresponding peer-reviewed publications. In this systematic review with a cross-sectional comparative...

Thought problems and attention problems are common in childhood and are important for later-emerging psychological disorders, yet less is known about the early childhood predictors underpinning such problems. We examined whether early childhood theory of mind (ToM) and effortful control (EC) constitute predictors for preadolescent thought and attention problems. We longitudinally tracked 214 children's ToM and EC, assessed with behavioral tasks, at ages 3 and 6, along with their thought and...

Earth's lower atmosphere is a vital ecological habitat, home to trillions of organisms that live, forage, and migrate through this medium. Despite its importance, this space is seldom considered a primary habitat for ecological or conservation prioritization, making it one of the least studied environments. However, it plays a crucial role as a global conduit for the transfer of biomass, weather, and inorganic materials. Fundamental research is essential to address core ecological questions...

Background: In 2013, Comanche County Memorial Hospital in Lawton, OK, in collaboration with the University of Oklahoma Medical Center, established a satellite level II neonatal intensive care unit (NICU) in southwest Oklahoma by utilizing a hybrid telemedicine model. The satellite level II NICU began offering telemedicine for retinal imaging (Tele-ROP) in July 2017. The availability of the Tele-ROP program has expanded access to retinopathy of prematurity (ROP) screening, allowing lower-risk...

CONCLUSIONS: ctDNA status on-PARPi was a stronger predictor of disease progression compared to CA-125 or BRCA/HR status. While additional analyses are warranted, our data suggest that ctDNA is a promising biomarker for therapeutic decision-making.